Gencurix Inc
229000
Company Profile
Business description
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.
Contact
9th Floor, Hanhwa Bizmetro I
Guro 3-dong, Guro-gu
Seoul152-733
KORT: +82 226217038
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
69
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,815.70 | 98.20 | -1.24% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,590.83 | 90.95 | -0.44% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 33,148.45 | 1,460.55 | -4.22% |
| NZX 50 Index | 12,023.68 | 177.75 | -1.46% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,610.90 | 98.70 | -1.28% |
| SSE Composite Index | 3,212.70 | 10.94 | -0.34% |